SA
MDT icon

Seneschal Advisors’s Medtronic MDT Stock Holding History

Seneschal Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$705 Sell
9
-1
-10% -$81 ﹤0.01% 326
2026
Q1 		$867 Hold
10
– – ﹤0.01% 257
2025
Q4 		$961 Hold
10
– – ﹤0.01% 235
2025
Q3 		$953 Buy
+10
New +$919 ﹤0.01% 244

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Seneschal Advisors's MDT Position: Q2 2026 in Review

Seneschal Advisors reduced its Medtronic (MDT) stake by 10% in Q2 2026, selling an estimated $81 and leaving 9 shares worth $705. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Seneschal Advisors first reported a position in MDT in Q3 2025 and has held it in 4 quarters since. The position peaked at $961 in Q4 2025. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Seneschal Advisors held 9 shares of Medtronic worth $705 as of Q2 2026.
  • Seneschal Advisors sold 1 Medtronic share in Q2 2026, an estimated $81.
  • Medtronic made up ﹤0.01% of Seneschal Advisors's portfolio in Q2 2026, its #326 holding.
  • Seneschal Advisors first reported a position in Medtronic in Q3 2025 and has held it in 4 quarters since.
  • Seneschal Advisors's Medtronic position peaked at $961 in Q4 2025.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Seneschal Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.